DarioHealth (DRIO) Amortization of Deferred Charges (2019 - 2024)

DarioHealth posted quarterly Amortization of Deferred Charges of $84000.0 for Q4 2024, up 221.74% year-on-year from $26108.1 in Q1 2024, and down 63.16% on a QoQ basis from $228000.0 in Q3 2024.

DarioHealth (DRIO) has 3 years of Amortization of Deferred Charges data on file, last reported at $84000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Amortization of Deferred Charges rose 221.74% year-over-year to $84000.0; the trailing twelve-month figure through Dec 2024 stood at $9000.0 (changed N/A YoY), and the FY2024 full-year result was $516000.0, down 56.93% from the prior year.
  • Amortization of Deferred Charges for Q4 2024 stood at $84000.0, down from $228000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $228000.0 in Q3 2024 and bottomed at -$234000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 DarioHealth 50.62 Mn 50.62 Mn 3.20 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 84,000.00
Dec 31, 2024 84,000.00
Sep 30, 2024 228,000.00
Sep 30, 2024 228,000.00
Dec 31, 2023 -69,000.00
Dec 31, 2023 -69,000.00
Sep 30, 2023 -234,000.00
Sep 30, 2023 -234,000.00
Sep 30, 2019 30,000.00
Sep 30, 2019 30,000.00